Mark your calendars! We have been selected for a poster presentation at the American Society of Clinical Oncology (ASCO) #ASCO24 Annual Meeting. Join us on June 1st as we present a sub-analysis of the MSS colorectal cancer cohort from our Phase 1b study of botensilimab and balstilimab. See the details here: https://bit.ly/44eR53n
Agenus’ Post
More Relevant Posts
-
Medical Doctor na European Association of Nuclear Medicine (EANM)
Joint EANM‑SNMMI guideline on the role of 2‑[18F]FDG PET/CT in no special type breast cancer (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA) - Summary of the 2-[18F]FDG PET/CT recommendations according to the clinical scenario in NST breast cancer
-
-
WATCH: Following ASCO GU 2024, a panel of GU medical oncologists discuss recent updates in bladder cancer and provide comprehensive insights on the evolving treatment landscape. #GU24 #oncology https://lnkd.in/eHmfnAwi
-
This seems an ambitious accelerated approval in UC - Tom Powles https://lnkd.in/gBVsyecJ #oncodaily #oncology #cancer #TDXD #FDAApproval #HER2Positive #CancerTreatment #UrothelialCancer #OncologyInnovation
Tom Powles: This seems an ambitious accelerated approval in UC - OncoDaily
oncodaily.com
-
Check out our abstract presentation from #ASCO2023, “Lasofoxifene plus abemaciclib for treating ESR1-mutated ER+/HER2- metastatic breast cancer after progression on prior therapies,” now on our website! The American Society of Clinical Oncology (ASCO) updated its guidelines to recommend routine testing for the emergence of ESR1 mutations. Review it now: https://bit.ly/3oYcaij #ICYMI #ELAINEStudies
-
-
Join a conversation The ASCO Post with Wenxin Xu and I as we dissect recent data to guide therapy! - Michael Serzan #ASCOPost #Cancer #KidneyCancer #MichaelSerzan #OncoDaily #Oncology #WenxinXu
Michael Serzan: Join a conversation The ASCO Post with Wenxin Xu and I as we dissect recent data to guide therapy! - Oncodaily | Oncology News, Insights, Stories
oncodaily.com
-
Learn more about what was discussed during this major international conference - European School of Oncology #ABC7 #BreastCancer #Cancer #EuropeanSchoolOfOncology #OncoDaily #Oncology
Learn more about what was discussed during this major international conference - European School of Oncology - OncoDaily
oncodaily.com
-
Explore key takeaways from ASCO GU 2024 with Prof Christof Vulsteke. From the UNITE to EV-302 trials, uncover how the latest research is revolutionizing urothelial cancer treatment. Discover these vital insights. 👇 For all ASCO GU 2024 videos, find the link in the comments! #MediMix #ASCOGU2024 #UrothelialCancer #Oncology
-
For #TrialTuesday, Sara Tolaney, MD, of Dana-Farber Cancer Institute, leads Alliance trial A012103 to compare the effect of pembrolizumab to observation in patients with triple-negative #breast cancer who had a pathologic complete response after chemotherapy plus pembrolizumab. To learn about this trial, visit https://lnkd.in/gf_bQiqD #NCI #NCTN
-